XBI - SPDR S&P Biotech - Stock Price & Dividends

Exchange: USA Stocks • Country: USA • Currency: USD • Type: Etf • ISIN: US78464A8707 • Health

Biotechnology, Pharmaceuticals, Vaccines, Medical, Diagnostics, Research, Therapies

The SPDR S&P Biotech ETF (XBI) is an exchange-traded fund that aims to replicate the performance of the S&P Biotechnology Select Industry Index. To achieve this, the fund uses a sampling strategy, which means it selects a representative sample of securities from the index to invest in.

The fund typically invests at least 80% of its total assets in the securities that make up the index. This index, in turn, represents the biotechnology segment of the broader S&P Total Market Index (S&P TMI), which tracks the US stock market.

By investing in the SPDR S&P Biotech ETF, you'll gain exposure to a diverse range of biotechnology companies, from small-cap to large-cap, that are driving innovation and advancements in the biotech industry. This can be a great way to tap into the growth potential of this exciting and rapidly evolving sector.

The fund is listed on the NYSE Arca exchange under the ticker symbol XBI, and you can find more information about it on the SPDR website at http://www.spdrs.com.

As a US-domiciled fund, the SPDR S&P Biotech ETF is subject to US regulations and is designed to provide investors with a convenient and cost-effective way to access the biotech sector.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for XBI - SPDR S&P Biotech  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for XBI - SPDR S&P Biotech  - Stock Price & Dividends

XBI ETF Overview

Market Cap in USD 6,870m
Category Health
TER 0.35%
IPO / Inception 2006-01-31

XBI ETF Ratings

Growth 5y 5.61
Fundamental -
Dividend 0.00
Rel. Performance vs Sector -0.28
Analysts -
Fair Price Momentum 88.55 USD
Fair Price DCF -

XBI Dividends

Dividend Yield 12m 0.13%
Yield on Cost 5y 0.15%
Dividends CAGR 5y -50.81%
Payout Consistency 51.2%

XBI Growth Ratios

Growth 12m 14.92%
Growth Correlation 12m 48%
Growth Correlation 3m 65%
CAGR 5y 2.64%
CAGR/Mean DD 5y 0.08
Sharpe Ratio 12m 0.34
Alpha vs SP500 12m -9.94
Beta vs SP500 5y weekly 1.10
ValueRay RSI 70.68
Volatility GJR Garch 1y 24.53%
Price / SMA 50 5.44%
Price / SMA 200 13.12%
Current Volume 5338.8k
Average Volume 20d 8229.1k

External Links for XBI ETF

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of XBI stocks?
As of July 21, 2024, the stock is trading at USD 97.51 with a total of 5,338,800 shares traded.
Over the past week, the price has changed by -1.47%, over one month by +8.61%, over three months by +17.87% and over the past year by +17.05%.
What are the forecast for XBI stock price target?
According to ValueRays Forecast Model, XBI SPDR S&P Biotech will be worth about 98.8 in July 2025. The stock is currently trading at 97.51. This means that the stock has a potential upside of +1.31%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 98.8 1.31